Vanda Pharmaceuticals Inc.

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP VNDA

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/14/2026

Shares

241,430

Value ($000)

1,668

Weight

0.0%

2021 Q2 - 2026 Q1 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/14/2026	1,668	0.0%	241,430	3/31/2026
2023 Q3	11/14/2023	129	0.0%	29,778	9/30/2023
2022 Q1	5/13/2022	1,151	0.0%	101,763	3/31/2022
2021 Q4	2/14/2022	4,150	0.0%	264,529	12/31/2021
2021 Q3	11/12/2021	5,866	0.0%	342,243	9/30/2021
2021 Q2	8/13/2021	9,065	0.0%	421,422	6/30/2021